Aberdeen Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $19.7M | Buy |
|
|||||
|
2025
Q2 | $8.21M | Buy |
|
|||||
|
2025
Q1 | $6.59M | Buy |
|
|||||
|
2024
Q4 | $2.28M | Sell |
|
|||||
|
2024
Q3 | $2.93M | Sell |
|
|||||
|
2024
Q2 | $31.3M | Sell |
|
|||||
|
2024
Q1 | $39.4M | Buy |
|
|||||
|
2023
Q4 | $35.3M | Sell |
|
|||||
|
2023
Q3 | $101M | Sell |
|
|||||
|
2023
Q2 | $119M | Sell |
|
|||||
|
2023
Q1 | $143M | Buy |
|
|||||
|
2022
Q4 | $139M | Buy |
|
|||||
|
2022
Q3 | $138M | Sell |
|
|||||
|
2022
Q2 | $150M | Buy |
|
|||||
|
2022
Q1 | $87.5M | Sell |
|
|||||
|
2021
Q4 | $91.1M | Buy |
|
|||||
|
2021
Q3 | $65.1M | Sell |
|
|||||
|
2021
Q2 | $77.2M | Buy |
|
|||||
|
2021
Q1 | $1.25M | Buy |
|
|||||
|
2020
Q4 | $510K | Buy |
|